22-ICRAD Call 2 - Emerging porcine influenza and coronaviruses
Lead Research Organisation:
University of Leeds
Department Name: Mathematics
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Influenza and coronaviruses have caused some of the deadliest pandemics in humans, and swine are key viral reservoirs. Influenza viruses of type A (swIAV) and porcine respiratory coronavirus (PRCV) are enzootic in swine and target epithelial cells of the airways. Still, they differ in pathogenicity and immune control. Cattle are the natural host of influenza D virus, but it is now an emerging virus in swine (swIDV), and its pathogenesis remains underexplored. SwIAV has enormous and still increasing genetic diversity with many "reassortant" genotypes circulating simultaneously, and is a proven zoonotic and pandemic threat. The pandemic potential of PRCV and swIDV is uncertain.
We shall compare the transmission, pathogenesis and host tropism of 6 different swIAV genotypes, swIDV and PRCV, to address 4 questions: 1) What are the transmission dynamics of swIVs and PRCV between swine and from swine to ferrets, which are used as a model for humans. 2) What key early events and immune mediators govern the outcome of swIV and PRCV exposure and may tip the balance to mild or severe disease? 3) What is the zoonotic potential of swIV and PRCV? Do some of the novel H1 swIAV genotypes pose a higher risk than the well-known swIAV? How efficiently do swIDV and PRCV replicate in human airways? Which viral traits may contribute to host switching? 4) Can an integrated mathematical model of viral replication, transmission, pathogenesis and immune control identify key events in the virus-host interaction to inform control strategies?
We will perform in vivo studies (Q1-2) in the swine and ferret host, and in vitro studies (Q3) in differentiated airway cultures of swine, humans, and ferrets, with maximal similarity to the in vivo situation. Finally, we will use novel mathematical models to provide quantitative information from the integrated data (Q4).
Our results will help predict the zoonotic potential, transmission, and pathogenicity of existing and emerging swIVs and PRCVs
We shall compare the transmission, pathogenesis and host tropism of 6 different swIAV genotypes, swIDV and PRCV, to address 4 questions: 1) What are the transmission dynamics of swIVs and PRCV between swine and from swine to ferrets, which are used as a model for humans. 2) What key early events and immune mediators govern the outcome of swIV and PRCV exposure and may tip the balance to mild or severe disease? 3) What is the zoonotic potential of swIV and PRCV? Do some of the novel H1 swIAV genotypes pose a higher risk than the well-known swIAV? How efficiently do swIDV and PRCV replicate in human airways? Which viral traits may contribute to host switching? 4) Can an integrated mathematical model of viral replication, transmission, pathogenesis and immune control identify key events in the virus-host interaction to inform control strategies?
We will perform in vivo studies (Q1-2) in the swine and ferret host, and in vitro studies (Q3) in differentiated airway cultures of swine, humans, and ferrets, with maximal similarity to the in vivo situation. Finally, we will use novel mathematical models to provide quantitative information from the integrated data (Q4).
Our results will help predict the zoonotic potential, transmission, and pathogenicity of existing and emerging swIVs and PRCVs
